Trade BioMarin Pharmaceutical Inc - BMRN CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.23 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 62.35 |
| Open | 62.03 |
| 1-Year Change | -29.54% |
| Day's Range | 62.03 - 63.38 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 4, 2025 | 62.77 | 0.86 | 1.39% | 61.91 | 63.44 | 61.48 |
| Feb 3, 2025 | 62.35 | 0.45 | 0.73% | 61.90 | 63.03 | 61.51 |
| Jan 31, 2025 | 63.10 | -0.06 | -0.09% | 63.16 | 64.25 | 62.98 |
| Jan 30, 2025 | 63.77 | 0.78 | 1.24% | 62.99 | 64.13 | 62.95 |
| Jan 29, 2025 | 63.22 | 0.82 | 1.31% | 62.40 | 63.96 | 62.40 |
| Jan 28, 2025 | 62.97 | 1.18 | 1.91% | 61.79 | 63.40 | 61.63 |
| Jan 27, 2025 | 61.49 | -0.42 | -0.68% | 61.91 | 62.98 | 61.13 |
| Jan 24, 2025 | 61.47 | -0.44 | -0.71% | 61.91 | 62.96 | 61.23 |
| Jan 23, 2025 | 62.07 | 1.00 | 1.64% | 61.07 | 62.48 | 61.07 |
| Jan 22, 2025 | 61.69 | -0.37 | -0.60% | 62.06 | 62.54 | 61.53 |
| Jan 21, 2025 | 62.20 | 0.65 | 1.06% | 61.55 | 62.89 | 61.55 |
| Jan 17, 2025 | 61.43 | 0.23 | 0.38% | 61.20 | 62.25 | 61.20 |
| Jan 16, 2025 | 61.26 | -0.08 | -0.13% | 61.34 | 61.45 | 60.47 |
| Jan 15, 2025 | 61.23 | -2.43 | -3.82% | 63.66 | 64.41 | 61.23 |
| Jan 14, 2025 | 63.55 | -3.61 | -5.38% | 67.16 | 67.16 | 63.44 |
| Jan 13, 2025 | 66.94 | 0.31 | 0.47% | 66.63 | 67.39 | 65.79 |
| Jan 10, 2025 | 67.30 | 0.48 | 0.72% | 66.82 | 67.49 | 65.86 |
| Jan 8, 2025 | 68.29 | 0.91 | 1.35% | 67.38 | 69.55 | 66.96 |
| Jan 7, 2025 | 67.81 | 1.36 | 2.05% | 66.45 | 68.76 | 66.28 |
| Jan 6, 2025 | 66.92 | 0.79 | 1.19% | 66.13 | 67.65 | 66.13 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
BioMarin Company profile
About BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc is a biotechnology company. The Company develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. The Company’s portfolio consists of commercial products and multiple clinical and preclinical product candidates for the treatment of various diseases. The Company's commercial products include Aldurazyme (laronidase), Brineura (cerliponase alfa), Kuvan (sapropterin dihydrochloride), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Vimizim (elosulfase alpha) and Voxzogo (vosoritide). The Company's pipeline includes Valoctocogene Roxaparvovec for Severe Hemophilia A, Vosoritide for Achondroplasia, BMN 307 for Phenylketonuria (PKU) and BMN 331 for Hereditary Angioedema (HAE).
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, BioMarin Pharmaceutical Inc. revenues decreased 1% to $1.85B. Net loss before extraordinary items totaled $68M vs. income of $4.6M. Revenues reflect Kuvan1 segment decrease of 38% to $285.8M, Naglazyme1 segment decrease of 3% to $380.4M, United States segment decrease of 28% to $657.7M, Latin America segment decrease of 7% to $191.2M.
Equity composition
Common Stock $.001 Par, 04/11, 250M auth., 110,909,591 issd. Insiders own 0.26%. IPO 7/23/99, 4.5M shs. $13 by U.S. Bancorp Piper Jaffray. PO 12/01, 8,050,000 shs. @ $12 by UBS Warburg. 5/01, private placement 4,763,712 shares @ $9.45. PO 2/03, 7.5M shs @ $10 by UBS Warburg. PO 3/06 10,350,000 shs. @ $13/sh.
| Industry: | Biopharmaceuticals |
105 Digital Dr
NOVATO
CALIFORNIA 94949
US
News
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com